OneMedNet announces strategic collaboration with Navidence

OneMedNet (ONMD) announced a strategic collaboration with Navidence to help research organizations transform rapidly expanding healthcare data into clear, actionable real-world evidence. Pharmaceutical companies face growing pressure to integrate high-quality RWD for regulatory submissions, post-market surveillance, and AI model training. Navidence’s platform enables precise definition of health data needs via Computable Operational Definitions-standardized, executable queries that translate complex study criteria into consistent, computable form across datasets. This collaboration integrates Navidence’s CODefs with the OneMedNet iRWD platform powered by Palantir Foundry. This collaboration is intended to directly advance OneMedNet’s life sciences strategy by addressing core industry demands of faster, more precise and usable data for pharmaceutical and CRO customers, along with expanded opportunities in the rapidly growing RWD market enabling access to precisely defined, fit for purpose datasets across Drug development and Life sciences research; AI model training and validation Health economics and outcomes research; Regulatory-grade evidence generation; and Value-based healthcare analytics